Pasithea Therapeutics (KTTA) Insider Trading & Ownership → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free KTTA Stock Alerts $7.24 +0.29 (+4.17%) (As of 03:43 PM ET) Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Pasithea Therapeutics (NASDAQ:KTTA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage14.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$12,900.00Number OfInsiders Selling(Last 12 Months)0 Get KTTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Pasithea Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KTTA Insider Buying and Selling by Quarter Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. Pasithea Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/2/2023Lawrence SteinmanDirectorBuy1,500$8.60$12,900.00 (Data available from 1/1/2013 forward) KTTA Insider Trading Activity - Frequently Asked Questions Who is on Pasithea Therapeutics's Insider Roster? The list of insiders at Pasithea Therapeutics includes Avi Geller, David Delaney, Eric Shahinian, and Lawrence Steinman. Learn more on insiders at KTTA. What percentage of Pasithea Therapeutics stock is owned by insiders? 14.10% of Pasithea Therapeutics stock is owned by insiders. Learn more on KTTA's insider holdings. Which Pasithea Therapeutics insiders have been buying company stock? The following insiders have purchased KTTA shares in the last 24 months: Avi Geller ($71,032.00), David Delaney ($1,110.00), Eric Shahinian ($262,911.20), and Lawrence Steinman ($12,900.00). How much insider buying is happening at Pasithea Therapeutics? Insiders have purchased a total of 15,202 KTTA shares in the last 24 months for a total of $347,953.20 bought. More Insider Trading Tools from MarketBeat Related Companies: eFFECTOR Therapeutics Insider Selling Chemomab Therapeutics Insider Selling Lixte Biotechnology Insider Selling Trevena Insider Selling Clever Leaves Insider Selling Sunshine Biopharma Insider Selling TFF Pharmaceuticals Insider Selling Enveric Biosciences Insider Selling Shuttle Pharmaceuticals Insider Selling Cyclerion Therapeutics Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:KTTA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pasithea Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
